Related Experiment Video
Updated: Nov 28, 2025

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
Published on: December 13, 2024
Inactivation-mimicking block of the epithelial calcium channel TRPV6
Rajesh Bhardwaj1, Sonja Lindinger2, Arthur Neuberger3
1Department of Nephrology and Hypertension and Department of Biomedical Research, University of Bern, Inselspital, Freiburgstrasse 15, CH-3010 Bern, Switzerland.
Abstract:
Epithelial calcium channel TRPV6 plays vital roles in calcium homeostasis, and its dysregulation is implicated in multifactorial diseases, including cancers. Here, we study the molecular mechanism of selective nanomolar-affinity TRPV6 inhibition by (4-phenylcyclohexyl)piperazine derivatives (PCHPDs). We use x-ray crystallography and cryo-electron microscopy to solve the inhibitor-bound structures of TRPV6 and identify two types of inhibitor binding sites in the transmembrane region: (i) modulatory sites between the S1-S4 and pore domains normally occupied by lipids and (ii) the main site in the ion channel pore. Our structural data combined with mutagenesis, functional and computational approaches suggest that PCHPDs plug the open pore of TRPV6 and convert the channel into a nonconducting state, mimicking the action of calmodulin, which causes inactivation of TRPV6 channels under physiological conditions. This mechanism of inhibition explains the high selectivity and potency of PCHPDs and opens up unexplored avenues for the design of future-generation biomimetic drugs.
Insights
Researchers discovered how specific compounds inhibit the epithelial calcium channel TRPV6. These PCHPDs block the channel pore, offering a new strategy for developing selective TRPV6-targeting drugs.
Area of Science:
- Molecular biology
- Structural biology
- Pharmacology
Background:
- Epithelial calcium channel TRPV6 is crucial for calcium homeostasis.
- TRPV6 dysregulation is linked to various diseases, including cancers.
Purpose of the Study:
- To elucidate the molecular mechanism of selective TRPV6 inhibition by (4-phenylcyclohexyl)piperazine derivatives (PCHPDs).
- To identify inhibitor binding sites and understand the structural basis of PCHPDs' action.
Main Methods:
- X-ray crystallography and cryo-electron microscopy to determine inhibitor-bound TRPV6 structures.
- Mutagenesis, functional assays, and computational approaches to validate findings.
Main Results:
- Identified two types of inhibitor binding sites: modulatory sites and a main site within the ion channel pore.
- Demonstrated that PCHPDs plug the open TRPV6 pore, rendering the channel nonconducting.
- Mechanism mimics calmodulin-induced inactivation of TRPV6.
Conclusions:
- PCHPDs inhibit TRPV6 by physically blocking the ion pore, explaining their high selectivity and potency.
- This biomimetic inhibition mechanism provides a foundation for designing novel TRPV6-targeting therapeutics.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Mechanically-gated Ion Channels
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....

